HM Payson & Co’s Neogen NEOG Stock Holding History

HM Payson & Co’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-418	Closed	-$6K	–	981
2022 Q3	$6K	Hold	418	–	–	﹤0.01%	839
2022 Q2	$10K	Hold	418	–	–	﹤0.01%	807
2022 Q1	$13K	Hold	418	–	–	﹤0.01%	814
2021 Q4	$19K	Buy	418 +56	+15%	+$2.4K	﹤0.01%	771
2021 Q3	$16K	Hold	362	–	–	﹤0.01%	777
2021 Q2	$17K	Hold	362	–	–	﹤0.01%	771
2021 Q1	$16K	Buy	+362	New	+$15.2K	﹤0.01%	809

Other funds holding NEOG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

HM Payson & Co's NEOG Position: Q4 2022 in Review

HM Payson & Co sold out of Neogen (NEOG) in Q4 2022, closing a stake of 418 shares — an estimated $6K sold.

HM Payson & Co first reported a position in NEOG in Q1 2021 and held it in 7 quarters. The position peaked at $19K in Q4 2021. 370 funds tracked by Wall St. Rank hold NEOG as of Q4 2022.

HM Payson & Co reported no remaining Neogen position as of Q4 2022 after selling out during the quarter.
HM Payson & Co sold 418 Neogen shares in Q4 2022, an estimated $6K.
HM Payson & Co first reported a position in Neogen in Q1 2021 and held it in 7 quarters.
HM Payson & Co's Neogen position peaked at $19K in Q4 2021.
370 funds tracked by Wall St. Rank held Neogen as of Q4 2022.

Based on HM Payson & Co's 13F filing for Q4 2022, filed 6 Feb 2023.